uMotif buys ClinOne, adds digital trial tech expert
uMotif has acquired trial site tech platform developer ClinOne and expanded its executive team.
The acquisition will combine ClinOne’s technology with uMotif’s electronic clinical outcome assessment and patient reported outcome systems, according to CEO Steve Rosenberg. Financial terms were not disclosed.
“There are natural synergies between uMotif and ClinOne, and together, in addition to the most modern eCOA/ePRO solution on the market, we now offer customers best-in-class consent management along with several additional tools to alleviate the site and patient burden.”
In addition to offering consent management tools, ClinOne also provides systems designed to increase site productivity, enhance trial awareness, and the patient and caregiver experience.
ClinOne CEO Andrea Valente, who will join uMotif as COO of site operations, said: “We’re excited to integrate our solutions including eConsent, site productivity, and trial awareness for HCPs [healthcare providers] into uMotif’s platform. Together we offer a breadth of capabilities to customers, sites, and participants focused on quality, speed, and an effective, purposeful experience.”
The acquisition builds on the partnership uMotif and ClinOne formed in 2022. It also fits with the plan uMotif outlined after receiving a $25.5 million investment from Athyrium Capital Management in June of that year.
At the time uMotif said it would use the money to expand its “global capabilities to better serve our sponsors, partners and, most importantly, the patients we help take part in research.”
New CSO
In a separate statement, uMotif named Florence Mowlem as its new chief scientific officer. The firm described Mowlem as an expert in the use of digital health technologies (DHTs) and electronic capture systems of all COA types.
Rosenberg said, “We’re delighted Flo chose to join uMotif. Her deep and broad scientific expertise and progressive thinking support our continued strong growth and innovation as we help sponsors adopt modern methods that capture unprecedented amounts of data by easing the patient and site journey.”
DepositPhotos/thaneeh.gmail.com